F18-FDG labeled ABMSCT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for F18-FDG labeled ABMSCT, covering 2015-10-23 to 2015-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Tissue Distribution of F18-FDG Labeled ABMSCT in Patients With Type2 Diabetes Mellitus [Phase 1, Phase 2]